GENE ONLINE|News &
Opinion
Blog

Rajaneesh K. Gopinath

WRITTEN BY Rajaneesh K. Gopinath

Brukinsa Receives EU Approval for the Treatment of Rare Lymphoma
2021-11-27
Roche Gets Shareholders Nod to Repurchase $21B Equity Stake Held By Novartis
2021-11-27
Starpharma Announces Encouraging Interim Results for Prostate Cancer Drug
2021-11-27
Updated Trial Data Shows Lower Efficacy for Merck’s Oral COVID-19 Pill
2021-11-26
FDA Approves Aadi Bioscience’s First Product to Treat Rare Cancer
2021-11-23
Merck’s Keytruda Bags FDA Approval for Early Kidney Cancer in Adjuvant Setting
2021-11-18
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
Chroma Medicine Debuts with High Hopes for “Game-Changing” Epigenetic Genome Editors
2021-11-17
How is China Driving Global Progress in Innovation and Access? – A Discussion with BeiGene CEO John Oyler
2021-11-16
Canadian Regulators Give Go-Ahead for Diabetes Trial Using CRISPR, ViaCyte’s Gene-Edited Stem Cell-Derived Therapy
2021-11-16
FDA Approves First Interferon Therapy for Rare Blood Cancer
2021-11-15
Boston-Based Cancer Immunotherapy Startup Secures $45 Million in Series B
2021-11-15
Considering Manufacturing and Commercial Advantages, Poseida Makes Strategic Shift Towards Allogeneic CAR-T Products
2021-11-10
Amgen Announces Encouraging Full Data for Migraine Drug, Aimovig
2021-11-09
Novo Nordisk’s Weight Loss Drug Shines in Phase 3 Trial
2021-11-07
1 2 3 20
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!